Stocks · Health care · Surgical & Medical Instruments & Apparatus

ResMed|

RMD Clue Score85
United States Fiscal year ends June CIK 0000943819 Results filed 29 Oct 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Michael J. Farrell
7 Oct 2026
Chairman and CEO
Sold after exercise
4,991
$226.33
$1.13M
Michael J. Farrell
8 Sep 2026
Chairman and CEO
Sold after exercise
4,991
$222.44
$1.11M
Michael J. Farrell
7 Aug 2026
Chairman and CEO
Sold after exercise
4,991
$205.69
$1.03M
Michael J. Farrell
7 Jul 2026
Chairman and CEO
Sold after exercise
4,991
$218.55
$1.09M
Michael J. Farrell
8 Jun 2026
Chairman and CEO
Sold after exercise
4,991
$193.96
$968.06K
Michael J. Farrell
7 May 2026
Chairman and CEO
Sold after exercise
4,991
$207.82
$1.04M
Michael J. Farrell
7 Apr 2026
Chairman and CEO
Sold after exercise
4,991
$225.50
$1.13M
Michael J. Farrell
9 Mar 2026
Chairman and CEO
Sold after exercise
4,991
$251.03
$1.25M
Michael J. Farrell
9 Feb 2026
Chairman and CEO
Sold after exercise
4,991
$273.78
$1.37M
Michael J. Farrell
7 Jan 2026
Chairman and CEO
Sold after exercise
4,991
$248.46
$1.24M
Michael J. Farrell
8 Dec 2025
Chairman and CEO
Sold after exercise
4,991
$251.41
$1.25M
Michael J. Farrell
7 Nov 2025
Chairman and CEO
Sold after exercise
8,011
$249.75
$2.00M

What was left out

Form 4 filings counted 58
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 12
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 159,008
History held since 3 Oct 2006